KAPLAN GILLA 4
4 · Avalo Therapeutics, Inc. · Filed Jul 1, 2022
Insider Transaction Report
Form 4
KAPLAN GILLA
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-30+44,115→ 44,115 totalExercise: $0.50From: 2022-06-30Exp: 2032-06-30→ Common Stock (44,115 underlying)
Footnotes (1)
- [F1]100% of the stock option will immediately vest on the date that it is granted.